|12.09||+0.0900||+0.75%||Vol 109.12K||1Y Perf 51.00%|
|Apr 20th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||20.50||Analyst Rating||Strong Buy 1.00|
|Potential %||69.56||Finscreener Ranking||★★★★+ 56.72|
|Insiders Trans % 3/6/12 mo.||-/-100/-100||Value Ranking||★★★★ 57.43|
|Insiders Value % 3/6/12 mo.||-/-100/-100||Growth Ranking||★★★ 52.05|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-100/-100||Income Ranking||— -|
|Market Cap||313.98M||Earnings Rating||Strong Buy|
|Price Range Ratio 52W %||58.37||Earnings Date||13th May 2021|
Today's Price Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Q01 2019||-0.42||-9.27||-2 107.14|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||13th May 2021|
|Estimated EPS Next Report||-0.57|
|EPS Growth Next 5 Years %||4.80|
|Avg. Weekly Volume||108.20K|
|Avg. Monthly Volume||158.45K|
|Avg. Quarterly Volume||185.02K|
HOOKIPA Pharma Inc. (NASDAQ: HOOK) stock closed at 12.09 per share at the end of the most recent trading day (a 0.75% change compared to the prior day closing price) with a volume of 109.47K shares and market capitalization of 313.98M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 104 people. HOOKIPA Pharma Inc. CEO is Joern Aldag.
The one-year performance of HOOKIPA Pharma Inc. stock is 51%, while year-to-date (YTD) performance is 9.02%. HOOK stock has a five-year performance of %. Its 52-week range is between 7.28 and 15.52, which gives HOOK stock a 52-week price range ratio of 58.37%
HOOKIPA Pharma Inc. currently has a PE ratio of -7.40, a price-to-book (PB) ratio of 2.39, a price-to-sale (PS) ratio of 19.61, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -26.59%, a ROC of -34.82% and a ROE of -32.17%. The company’s profit margin is -%, its EBITDA margin is -217.40%, and its revenue ttm is $15.89 Million , which makes it $0.61 revenue per share.
Of the last four earnings reports from HOOKIPA Pharma Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.57 for the next earnings report. HOOKIPA Pharma Inc.’s next earnings report date is 13th May 2021.
The consensus rating of Wall Street analysts for HOOKIPA Pharma Inc. is Strong Buy (1), with a target price of $20.5, which is +69.56% compared to the current price. The earnings rating for HOOKIPA Pharma Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
HOOKIPA Pharma Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
HOOKIPA Pharma Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 6.63, ATR14 : 0.70, CCI20 : -146.22, Chaikin Money Flow : -0.15, MACD : 0.17, Money Flow Index : 38.00, ROC : -10.78, RSI : 33.37, STOCH (14,3) : 7.79, STOCH RSI : 0.00, UO : 38.00, Williams %R : -92.21), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of HOOKIPA Pharma Inc. in the last 12-months were: Igor Matushansky (Option Excercise at a value of $4 963), Igor Matushansky (Sold 28 359 shares of value $332 789 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.